{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:48:31Z","timestamp":1757702911743},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T00:00:00Z","timestamp":1305244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00223-011-9489-x","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T06:09:07Z","timestamp":1305180547000},"page":"21-28","source":"Crossref","is-referenced-by-count":8,"title":["Long-Term Effects of Neridronate and its Discontinuation in Patients with Primary Hyperparathyroidism"],"prefix":"10.1007","volume":"89","author":[{"given":"Maurizio","family":"Rossini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Kalpakcioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajoo","family":"Dhangana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vania","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fracassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvano","family":"Adami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,13]]},"reference":[{"key":"9489_CR1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","volume":"4","author":"SJ Silverberg","year":"1989","unstructured":"Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283\u2013291","journal-title":"J Bone Miner Res"},{"key":"9489_CR2","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415\u20135422","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","volume":"92","author":"J Bollerslev","year":"2007","unstructured":"Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug J-E, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687\u20131692","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR4","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C (2007) Surgery or surveillance of mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92:3114\u20133121","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","volume":"341","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249\u20131255","journal-title":"N Engl J Med"},{"key":"9489_CR6","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15\u00a0years. J Clin Endocrinol Metab 93:3462\u20133470","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR7","first-page":"S353","volume":"22","author":"J Iskander","year":"2007","unstructured":"Iskander J, Rao D (2007) Long term morbidity and mortality in untreated mild primary hyperparathyroidism. J Bone Miner Res 22:S353","journal-title":"J Bone Miner Res"},{"key":"9489_CR8","first-page":"18","volume":"121","author":"MJ Bolland","year":"2008","unstructured":"Bolland MJ, Grey AB, Orr-Walker BJ, Horne AM, Evans MC, Clearwater JM, Gamble GD, Reid IR (2008) Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism. N Z Med J 121:18\u201329","journal-title":"N Z Med J"},{"key":"9489_CR9","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","volume":"94","author":"E Vignali","year":"2009","unstructured":"Vignali E, Viccica G, Diacinti D, Cetani F, Cianferotti L, Ambrogini E, Banti C, Del Fiacco R, Bilezikian JP, Pinchera A, Marcocci C (2009) Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 94:2306\u20132312","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jc.2008-1762","volume":"94","author":"A Khan","year":"2009","unstructured":"Khan A, Grey A, Shoback D (2009) Medical management of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab 94:373\u2013381","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","volume":"88","author":"CC Chow","year":"2003","unstructured":"Chow CC, Chan WB, Li JK, Chan NW, Chan MHM, Ko GTC, Lo KW, Cockram CS (2003) Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 88:581\u2013587","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR12","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","volume":"89","author":"AA Khan","year":"2004","unstructured":"Khan AA, Bilezikian JP, Kung AW, Ahmed MM, Dubois SJ, Ho AYY, Schussheim D, Rubin MR, Shaikh AM, Silverberg SJ, Standish TI, Syed Z, Syed ZA (2004) Alendronate in primary hyperparathyroidism: a double blind, randomized, placebo controlled trial. J Clin Endocrinol Metab 89:3319\u20133325","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4158\/EP08178.ORR","volume":"15","author":"AA Khan","year":"2009","unstructured":"Khan AA, Bilezikian JP, Kung A, Syed ZA, Dubois SJ, Standish TI (2009) Alendronate therapy in men with primary hyperparathyroidism. Endocr Pract 15:705\u2013713","journal-title":"Endocr Pract"},{"key":"9489_CR14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","volume":"125","author":"AB Grey","year":"1996","unstructured":"Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR (1996) Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med 125:360\u2013368","journal-title":"Ann Intern Med"},{"key":"9489_CR15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","volume":"16","author":"M Rossini","year":"2001","unstructured":"Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Asami S (2001) Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. J Bone Miner Res 16:113\u2013119","journal-title":"J Bone Miner Res"},{"key":"9489_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01623394","volume":"6","author":"T Diamond","year":"1996","unstructured":"Diamond T, Ng AT, Levy S, Magarey C, Smart R (1996) Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report. Osteoporos Int 6:329\u2013333","journal-title":"Osteoporos Int"},{"key":"9489_CR17","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1210\/jc.2001-010385","volume":"87","author":"CR Parker","year":"2002","unstructured":"Parker CR, Blackwell PJ, Fairbairn KJ, Hosking DJ (2002) Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study. J Clin Endocrinol Metab 87:4482\u20134489","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR18","first-page":"488","volume":"35","author":"JA Eisman","year":"2008","unstructured":"Eisman JA, Civitelli R, Adami S, Czerwinski E, Recknor C, Prince R, Reginster JY, Zaidi M, Felsenberg D, Hughes C, Mairon N, Masanauskaite D, Reid DM, DElmas PD, Recker RR (2008) Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol 35:488\u2013497","journal-title":"J Rheumatol"},{"key":"9489_CR19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","volume":"346","author":"I Reid","year":"2002","unstructured":"Reid I, Brown J, Burckhardt P, Horowitz Z, Richardson P, Trechsel U, Widmer A, Devogelaer J, Kaufman J, Jaeger P, Body J, Brandi ML, Broell J, Di M, Genazzani A, Felsenberg D, Happ J, Hooper M, Ittner J, Leb G, Mallmin H, Murray T, Ortolani S, Rubinacci A, Saaf M, Samsioe G, Verbruggen L, Meunier P (2002) Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653\u2013661","journal-title":"N Engl J Med"},{"key":"9489_CR20","first-page":"55","volume":"20","author":"S Adami","year":"2002","unstructured":"Adami S, Bevilacqua M, Broggini M, Filipponi P, Ortolani S, Palummeri E, Ulivieri F, Nannipieri F, Braga V (2002) Short-term intravenous therapy with neridronate in Paget\u2019s disease. Clin Exp Rheumatol 20:55\u201358","journal-title":"Clin Exp Rheumatol"},{"key":"9489_CR21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","volume":"18","author":"S Adami","year":"2003","unstructured":"Adami S, Gatti D, Colapietro F, Fracassi E, Braga V, Rossini M, Tat\u00f2 L (2003) Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res 18:126\u2013130","journal-title":"J Bone Miner Res"},{"key":"9489_CR22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","volume":"20","author":"D Gatti","year":"2005","unstructured":"Gatti D, Antoniazzi F, Prizzi R, Braga V, Rossini M, Tat\u00f2 L, Viapiana O, Adami S (2005) Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res 20:758\u2013763","journal-title":"J Bone Miner Res"},{"key":"9489_CR23","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S8756-3282(03)00084-X","volume":"33","author":"V Braga","year":"2003","unstructured":"Braga V, Gatti D, Colapietro F, Battaglia E, Righetti D, Prizzi R, Rossini M, Adami S (2003) Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis. Bone 33:342\u2013345","journal-title":"Bone"},{"key":"9489_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00223-008-9179-5","volume":"83","author":"S Adami","year":"2008","unstructured":"Adami S, Gatti D, Bertoldo F, Sartori L, Di Munno O, Filipponi P, Marcocci C, Frediani B, Palummeri E, Fiore CE, Costi D, Rossini M (2008) Intramuscular neridronate in postmenopausal women with low bone mineral density. Calcif Tissue Int 83:301\u2013307","journal-title":"Calcif Tissue Int"},{"key":"9489_CR25","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021370","volume":"87","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian JP, Potts JT Jr, Gel-H Fuleihan, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353\u20135361","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","volume":"350","author":"HG Bone","year":"2004","unstructured":"Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA (2004) Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189\u20131199","journal-title":"N Engl J Med"},{"key":"9489_CR27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00223-008-9126-5","volume":"82","author":"S Adami","year":"2008","unstructured":"Adami S, Bianchi G, Brandi ML, Giannini S, Ortolani S, DiMunno O, Frediani B, Rossini M, BONTURNO Study Group (2008) Determinants of bone turnover markers in healthy premenopausal women. Calcif Tissue Int 82:341\u2013347","journal-title":"Calcif Tissue Int"},{"key":"9489_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsbmb.2010.03.077","volume":"121","author":"JC Souberbielle","year":"2010","unstructured":"Souberbielle JC, Maury E, Friedlander G, Cormier C (2010) Vitamin D and primary hyperparathyroidism. J Steroid Biochem Mol Biol 121:199\u2013203","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9489_CR29","doi-asserted-by":"crossref","unstructured":"Rossini M, Maddali Bongi S, La Montagna G, Minisola G, Malavolta N, Bernini L, Cacace E, Sinigaglia L, Di Munno O, Adami S (2010) Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and association with disease activity and disability. Arthritis Res Ther 12:R216","DOI":"10.1186\/ar3195"},{"key":"9489_CR30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bone.2007.10.003","volume":"42","author":"S Adami","year":"2008","unstructured":"Adami S, Viapiana O, Gatti D, Idolazzi L, Rossini M (2008) Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone 42:267\u2013270","journal-title":"Bone"},{"key":"9489_CR31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM198510313131804","volume":"313","author":"V Lo Cascio","year":"1985","unstructured":"Lo Cascio V, Adami S, Galvanini G, Cominacini L, Scuro LA (1985) Substrate\u2013product relation of 1-hydroxylase activity in primary hyperparathyroidism. N Engl J Med 313:1123\u20131125","journal-title":"N Engl J Med"},{"key":"9489_CR32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2265.1990.tb00504.x","volume":"33","author":"S Adami","year":"1990","unstructured":"Adami S, Mian M, Bertoldo F, Rossini M, Jayawerra P, O\u2019Riordan JL, Lo Cascio V (1990) Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment. Clin Endocrinol 33:391\u2013397","journal-title":"Clin Endocrinol"},{"key":"9489_CR33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","volume":"94","author":"JP Bilezikian","year":"2009","unstructured":"Bilezikian JP, Khan AA, Potts JT (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 94:335\u2013339","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR34","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","volume":"92","author":"J Bollerslev","year":"2007","unstructured":"Bollerslev J, Jansson S, Mollerup CL, Nordenstr\u00f6m J, Lundgren E, T\u00f8rring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation, compared with parathyroidectomy, for symptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687\u20131692","journal-title":"J Clin Endocrinol Metab"},{"key":"9489_CR35","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0140-6736(05)66782-7","volume":"365","author":"SJ Steddon","year":"2005","unstructured":"Steddon SJ, Cunningham J (2005) Calcimimetic and calcilytics\u2014fooling the calcium receptor. Lancet 365:2237\u20132239","journal-title":"Lancet"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-011-9489-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-011-9489-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-011-9489-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T18:42:30Z","timestamp":1560192150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-011-9489-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,13]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["9489"],"URL":"https:\/\/doi.org\/10.1007\/s00223-011-9489-x","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,13]]}}}